Rockwell Medical Inc

NASDAQ:RMTI  
1.06
+0.06 (+6.53%)
Earnings Announcements

Rockwell Medical Says Q3 Sales Fell 0.8%

Published: 11/09/2020 22:32 GMT
Rockwell Medical Inc (RMTI) - Q3 Loss per Share $0.10.
Q3 Sales Fell 0.8 Percent to $15.3 Million.
Poised to Enroll First Patient in Phase 3 Clinical Trial of Triferic in China.
Ended Quarter With $67.3 Million in Cash, Cash Equivalents and Investments.
Revenue is expected to be $19.66 Million
Adjusted EPS is expected to be -$0.08

Next Quarter Revenue Guidance is expected to be $28.6 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.